{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:27:15Z","timestamp":1761895635788},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T00:00:00Z","timestamp":1360713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s15010-013-0419-x","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T09:32:12Z","timestamp":1360661532000},"page":"663-668","source":"Crossref","is-referenced-by-count":11,"title":["Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination"],"prefix":"10.1007","volume":"41","author":[{"given":"A.-L.","family":"Munier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"de Lastours","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Varon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Donay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,13]]},"reference":[{"key":"419_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QAD.0b013e32834dcf27","volume":"26","author":"Z Yin","year":"2012","unstructured":"Yin Z, Rice BD, Waight P, Miller E, George R, Brown AE, et al. Invasive pneumococcal disease among HIV-positive individuals, 2000\u20132009. AIDS. 2012;26:87\u201394.","journal-title":"AIDS"},{"key":"419_CR2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1086\/420933","volume":"38","author":"Q Jordano","year":"2004","unstructured":"Jordano Q, Falc\u00f3 V, Almirante B, Planes AM, Del Valle O, Ribera E, et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis. 2004;38:1623\u20138.","journal-title":"Clin Infect Dis"},{"key":"419_CR3","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","volume":"196","author":"LA Hicks","year":"2007","unstructured":"Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004. J Infect Dis. 2007;196:1346\u201354.","journal-title":"J Infect Dis"},{"key":"419_CR4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1086\/339882","volume":"185","author":"MC McEllistrem","year":"2002","unstructured":"McEllistrem MC, Mendelsohn AB, Pass MA, Elliott JA, Whitney CG, Kolano JA, et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis. 2002;185:1364\u20138.","journal-title":"J Infect Dis"},{"key":"419_CR5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","volume":"192","author":"MH Kyaw","year":"2005","unstructured":"Kyaw MH, Rose CE Jr, Fry AM, Singleton JA, Moore Z, Zell ER, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192:377\u201386.","journal-title":"J Infect Dis"},{"key":"419_CR6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1468-1293.2009.00717.x","volume":"10","author":"I Grau","year":"2009","unstructured":"Grau I, Ardanuy C, Li\u00f1ares J, Podzamczer D, Schulze MH, Pallares R. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease. HIV Med. 2009;10:488\u201395.","journal-title":"HIV Med"},{"key":"419_CR7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(95)91714-4","volume":"346","author":"J Paul","year":"1995","unstructured":"Paul J, Kimari J, Gilks CF. Streptococcus pneumoniae resistant to penicillin and tetracycline associated with HIV seropositivity. Lancet. 1995;346:1034\u20135.","journal-title":"Lancet"},{"key":"419_CR8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.aids.0000206507.54901.84","volume":"20","author":"PM Barry","year":"2006","unstructured":"Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990\u20132003. AIDS. 2006;20:437\u201344.","journal-title":"AIDS"},{"key":"419_CR9","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1086\/520977","volume":"45","author":"M Pe\u00f1aranda","year":"2007","unstructured":"Pe\u00f1aranda M, Falco V, Payeras A, Jordano Q, Curran A, Pareja A, et al. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Clin Infect Dis. 2007;45:e82\u20137.","journal-title":"Clin Infect Dis"},{"key":"419_CR10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/319218","volume":"32","author":"MS Dworkin","year":"2001","unstructured":"Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis. 2001;32:794\u2013800.","journal-title":"Clin Infect Dis"},{"key":"419_CR11","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archinte.165.13.1533","volume":"165","author":"I Grau","year":"2005","unstructured":"Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med. 2005;165:1533\u201340.","journal-title":"Arch Intern Med"},{"key":"419_CR12","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","volume":"355","author":"N French","year":"2000","unstructured":"French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet. 2000;355:2106\u201311.","journal-title":"Lancet"},{"key":"419_CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2334-7-119","volume":"7","author":"MASM Veras","year":"2007","unstructured":"Veras MASM, Enanoria WTA, Castilho EA, Reingold AL. Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study. BMC Infect Dis. 2007;7:119.","journal-title":"BMC Infect Dis"},{"key":"419_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1468-1293.2010.00892.x","volume":"12","author":"R Pedersen","year":"2011","unstructured":"Pedersen R, Lohse N, \u00d8stergaard L, S\u00f8gaard O. The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review. HIV Med. 2011;12:323\u201333.","journal-title":"HIV Med"},{"key":"419_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","volume":"180","author":"A Huss","year":"2009","unstructured":"Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. Can Med Assoc J. 2009;180:48\u201358.","journal-title":"Can Med Assoc J"},{"key":"419_CR16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.medmal.2010.06.005","volume":"40","author":"M Mohseni-Zadeh","year":"2010","unstructured":"Mohseni-Zadeh M, Rey D, Batard M-L, Beck Wirth G, Partisani M-L, Lang J-M, et al. Inadequate vaccination coverage in a French cohort of HIV positive patients. Med Mal Infect. 2010;40:683\u201390.","journal-title":"Med Mal Infect"},{"key":"419_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-111-2-133","volume":"111","author":"Centers for Disease Control","year":"1989","unstructured":"Centers for Disease Control. General recommendations on immunization. Guidelines from the immunization practices advisory committee. Ann Intern Med. 1989;111:133\u201342.","journal-title":"Ann Intern Med"},{"key":"419_CR18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1086\/432721","volume":"41","author":"D Guillemot","year":"2005","unstructured":"Guillemot D, Varon E, Bern\u00e8de C, Weber P, Henriet L, Simon S, et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis. 2005;41:930\u20138.","journal-title":"Clin Infect Dis"},{"key":"419_CR19","unstructured":"Varon E, Janoir C, Gutmann L. Centre national de r\u00e9f\u00e9rence des pneumocoques. Rapport d\u2019activit\u00e9 2009. Epid\u00e9miologie 2008. Available at: http:\/\/www.invs.sante.fr\/surveillance\/cnr\/rapport_cnrp_2009.pdf ."},{"key":"419_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/clinids\/22.3.437","volume":"22","author":"JL Meynard","year":"1996","unstructured":"Meynard JL, Barbut F, Blum L, Guiguet M, Chouaid C, Meyohas MC, et al. Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Clin Infect Dis. 1996;22:437\u201340.","journal-title":"Clin Infect Dis"},{"key":"419_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/mdr.2010.0031","volume":"17","author":"M Kempf","year":"2011","unstructured":"Kempf M, Baraduc R, Bonnabau H, Brun M, Chabanon G, Chardon H, et al. Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in France in 2007: data from the pneumococcus surveillance network. Microb Drug Resist. 2011;17:31\u20136.","journal-title":"Microb Drug Resist"},{"key":"419_CR22","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1086\/592972","volume":"47","author":"MR Jacobs","year":"2008","unstructured":"Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis. 2008;47:1388\u201395.","journal-title":"Clin Infect Dis"},{"key":"419_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-144-1-200601030-00004","volume":"144","author":"B Flannery","year":"2006","unstructured":"Flannery B, Heffernan RT, Harrison LH, Ray SM, Reingold AL, Hadler J, et al. Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med. 2006;144:1\u20139.","journal-title":"Ann Intern Med"},{"key":"419_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)01280-6","volume":"5","author":"WP Hausdorff","year":"2005","unstructured":"Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005;5:83\u201393.","journal-title":"Lancet Infect Dis"},{"key":"419_CR25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMe068038","volume":"354","author":"DM Musher","year":"2006","unstructured":"Musher DM. Pneumococcal vaccine-direct and indirect (\u201cherd\u201d) effects. N Engl J Med. 2006;354:1522\u20134.","journal-title":"N Engl J Med"},{"key":"419_CR26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/514004","volume":"175","author":"EN Janoff","year":"1997","unstructured":"Janoff EN, Fasching C, Ojoo JC, O\u2019Brien J, Gilks CF. Responsiveness of human immunodeficiency virus type 1-infected Kenyan women with or without prior pneumococcal disease to pneumococcal vaccine. J Infect Dis. 1997;175:975\u20138.","journal-title":"J Infect Dis"},{"key":"419_CR27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1086\/421911","volume":"190","author":"N French","year":"2004","unstructured":"French N, Moore M, Haikala R, Kayhty H, Gilks CF. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults. J Infect Dis. 2004;190:707\u201312.","journal-title":"J Infect Dis"},{"key":"419_CR28","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","volume":"362","author":"N French","year":"2010","unstructured":"French N, Gordon SB, Mwalukomo T, White SA, Mwafulirwa G, Longwe H, et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med. 2010;362:812\u201322.","journal-title":"N Engl J Med"},{"key":"419_CR29","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0b013e3282887e91","volume":"21","author":"P Lesprit","year":"2007","unstructured":"Lesprit P, P\u00e9drono G, Molina J-M, Goujard C, Girard P-M, Sarrazin N, et al. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. AIDS. 2007;21:2425\u201334.","journal-title":"AIDS"},{"key":"419_CR30","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","volume":"349","author":"KP Klugman","year":"2003","unstructured":"Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003;349:1341\u20138.","journal-title":"N Engl J Med"},{"key":"419_CR31","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1016\/j.vaccine.2010.09.056","volume":"28","author":"NF Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone NF, Roediger M, Huppler Hullsiek K, Ganesan A, Landrum M, Weintrob A, et al. The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection. Vaccine. 2010;28:7583\u20138.","journal-title":"Vaccine"},{"key":"419_CR32","doi-asserted-by":"crossref","unstructured":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816\u2013819.","DOI":"10.1111\/ajt.12073"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-013-0419-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0419-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T16:47:04Z","timestamp":1562690824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-013-0419-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,13]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1007\/s15010-013-0419-x","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,13]]}}}